EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial

Conditions:   Type 2 Diabetes;   Obesity Interventions:   Other: Weight Management Program (WMP);   Other: Traditional care;   Drug: Phentermine / Topiramate Extended Release Oral Capsule;   Drug: naltrexone/bupropion extended-release;   Drug: liraglutide 3.0 mg;   Drug: Orlistat Sponsor:   The Cleveland Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials